Research Progress in the Understanding and Treatment of Pediatric Bronchial Asthma in Traditional Chinese and Western Medicine
梦玲 王
No information about this author
Nursing Science,
Journal Year:
2025,
Volume and Issue:
14(02), P. 235 - 242
Published: Jan. 1, 2025
Language: Английский
The association between COVID-19 vaccine/infection and new-onset asthma in children - based on the global TriNetX database
Infection,
Journal Year:
2024,
Volume and Issue:
unknown
Published: June 21, 2024
The
COVID-19
pandemic
has
underscored
the
importance
of
its
potential
long-term
health
effects,
including
link
to
new-onset
asthma
in
children.
Asthma
significantly
impacts
children's
health,
causing
adverse
outcomes
and
increased
absenteeism.
Emerging
evidence
suggests
a
association
between
infection
higher
rates
adults,
raising
concerns
about
impact
on
respiratory
health.
Language: Английский
Treatment of Severe Asthma: Case Report of Fast Action of Mepolizumab in a Patient with Recent SARS-CoV-2 Infection
Life,
Journal Year:
2024,
Volume and Issue:
14(9), P. 1063 - 1063
Published: Aug. 25, 2024
Asthma
is
one
of
the
most
common
chronic
inflammatory
diseases
childhood
with
a
heterogeneous
impact
on
health
and
quality
life.
Mepolizumab
an
antagonist
interleukin-5,
indicated
as
adjunct
therapy
for
severe
refractory
eosinophilic
asthma
in
adolescents
children
aged
>6
years
old.
We
present
case
9
year-old
boy
who
experienced
several
asthmatic
exacerbations
following
SARS-CoV-2
infection,
necessitating
short-acting
bronchodilators,
oral
corticosteroids,
hospitalization.
follow
patient
using
validated
questionnaires
evaluation
control:
Children
Control
Test,
Questionnaire,
respiratory
function
tests,
exhaled
nitric
oxide
fraction.
After
12
weeks
from
start
mepolizumab,
we
found
significant
improvements
lung
function,
reduction
degree
bronchial
inflammation,
No
have
been
reported
since
initiation
treatment
mepolizumab.
Respiratory
infections,
such
those
related
to
SARS-CoV-2,
represent
risk
factor
patients
moderate
forms
asthma.
In
our
experience,
new
episodes
exacerbation,
mepolizumab
has
allowed
us
improve
control
enhance
life
first
doses.
Although
showed
promise
this
child
during
results
single
cannot
be
generalized.
Further
studies
are
needed
confirm
its
safety
effectiveness.
Language: Английский
Predicting the Risk of Asthma Development in Youth Using Machine Learning Models
Matthew Xie,
No information about this author
Chenliang Xu
No information about this author
medRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: June 26, 2024
Asthma
is
a
chronic
respiratory
disease
characterized
by
wheezing
and
difficulty
breathing,
which
disproportionally
affects
4.7
million
children
in
the
U.S.
Currently,
there
lack
of
asthma
predictive
models
for
youth
with
good
performance.
This
study
aims
to
build
machine
learning
better
predict
development
using
easily
accessible
national
survey
data.
We
analyzed
cross-sectional
combined
2021
2022
National
Health
Interview
Survey
(NHIS)
data
from
9,716
subjects
their
corresponding
parent
information.
built
several
various
sampling
techniques
(under-
or
over-sampling)
prediction
youth,
including
XGBoost,
Neural
Networks,
Random
Forest,
Support
Vector
Machine
(SVM),
Logistic
Regression.
examined
associations
potential
risk
factors
identified
both
Forest
Least
Absolute
Shrinkage
Selection
Operator
(LASSO)
youth.
Between
different
techniques,
undersampling
major
class
(subjects
without
asthma)
yielded
best
results
terms
area
under
curve
(AUC)
F1
scores
models.
The
Regression
performed
under-sampled
data,
yielding
an
AUC
score
0.7654
0.3452.
In
addition,
we
have
additional
important
associated
such
as
low
family
poverty
ratio
parents
ever
had
asthma.
successfully
model
will
be
early
screening
detection
Language: Английский